5 However, the management of T2DM is still described as complex, particularly due to its multifactorial causes, chronic nature, and the frequent presence of comorbid conditions
May improve sleep quality by regulating circadian rhythms, reducing 3AM wake-ups, supporting better cortisol management and daytime cognitive function
Amgen did say on the call that it has initiated six global Phase III studies for the drug, with more planned this year
Glapp does not tell you what dose to take or replace medical advice
But the reports keep coming, from rheumatologists, from immunologists, from people who have tried everything and finally found something that shifted the needle on inflammation they could not control for years
Lancet 372, 14111426